Clinical Trial Update: Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of docetaxel and PROSTVAC for metastatic castration-sensitive prostate cancer has completed. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PROSTVAC-VF (PROSTVAC-VF)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Prostate Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2023-07-21